Literature DB >> 15681744

Involvement of dendritic cell subsets in the induction of oral tolerance and immunity.

Marina Fleeton1, Nikhat Contractor, Francisco Leon, Jianping He, Denise Wetzel, Terence Dermody, Akiko Iwasaki, Brian Kelsall.   

Abstract

Dendritic cells (DCs) play a central role in the generation of immune responses in the intestine. DCs induce differentiation and tolerance of T cells, and may have a direct role in B cell switching to IgA. Four distinct subsets of CD11c(+) DCs are present in murine Peyer's patches, which represent primary sites for the induction of mucosal T and B cell responses. Studies suggest that CD11b(+) DCs or plasmacytoid DCs may be specialized for the induction of regulatory T cells, and CD8alpha(+) DCs for the induction of clonal deletion in response to soluble oral antigen, while all DC subsets (including CD8alpha(-)/CD11b(-) DCs) may be involved in responses to pathogens. We are currently using reovirus type-1 Lang (TIL) to explore the role of DC populations in mucosal immunity in vivo, as oral administration of live T1L to mice induces strong mucosal and systemic antiviral immune responses, whereas oral administration of inactivated T1L results in tolerance to viral proteins. We found that primary infection with T1L occurs in epithelial cells of the PP follicle-associated epithelium, but that CD8alpha(-)/CD11b(-) DCs in the subepithelial dome region (SED) are loaded with T1L antigens in the absence of active DC infection. At least a portion of this antigen is associated with cell fragments from apoptotic epithelial cells, demonstrating that SED DCs cross-present antigens from apoptotic epithelial cells. In vitro, in contrast to exposure to several TLR-ligands or anti-CD40, exposure to T1L does not activate DCs to mature or to produce cytokines, despite clear loading of the DCs with viral antigens. These data suggest that T1L is taken up by a "silent" receptor on DCs, and that the induction of immunity to T1L is dependent on signals from non-DCs following active viral infection that induce DC maturation. Thus, the decision between tolerance and immunity to inactive and live virus, respectively, likely depends on whether there is active infection of epithelial cells by T1L, which results in the elaboration of molecules, such as cytokines, that induce DC maturation.

Entities:  

Mesh:

Year:  2004        PMID: 15681744     DOI: 10.1196/annals.1309.008

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

2.  CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches.

Authors:  Rosa Maria Salazar-Gonzalez; Jan H Niess; David J Zammit; Rajesh Ravindran; Aparna Srinivasan; Joseph R Maxwell; Thomas Stoklasek; Rajwardhan Yadav; Ifor R Williams; Xiubin Gu; Beth A McCormick; Michael A Pazos; Anthony T Vella; Leo Lefrancois; Hans-Christian Reinecker; Stephen J McSorley
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

3.  IFN-gamma-producing dendritic cells are important for priming of gut intraepithelial lymphocyte response against intracellular parasitic infection.

Authors:  Magali M Moretto; Louis M Weiss; Crescent L Combe; Imtiaz A Khan
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

4.  Aging correlates with reduction in regulatory-type cytokines and T cells in the gut mucosa.

Authors:  Andrezza F Santiago; Andréa C Alves; Rafael P Oliveira; Raphaela M Fernandes; Josiely Paula-Silva; Frankcineia A Assis; Cláudia R Carvalho; Howard L Weiner; Ana Maria C Faria
Journal:  Immunobiology       Date:  2011-05-14       Impact factor: 3.144

5.  Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease.

Authors:  Karen Chase Lencioni; Audrey Seamons; Piper M Treuting; Lillian Maggio-Price; Thea Brabb
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

6.  Reovirus serotypes elicit distinctive patterns of recall immunity in humans.

Authors:  Renée N Douville; Ruey-Chyi Su; Kevin M Coombs; F Estelle R Simons; Kent T Hayglass
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

7.  Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.

Authors:  Agnieszka Rynda; Massimo Maddaloni; Dagmara Mierzejewska; Javier Ochoa-Repáraz; Tomasz Maslanka; Kathryn Crist; Carol Riccardi; Beata Barszczewska; Kohtaro Fujihashi; Jerry R McGhee; David W Pascual
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

Review 8.  Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines.

Authors:  Kosuke Kataoka; Kohtaro Fujihashi
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

9.  Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2.

Authors:  Chang Hoon Lee; Hesham F Nawar; Lorrie Mandell; Shuang Liang; George Hajishengallis; Terry D Connell
Journal:  Vaccine       Date:  2010-03-21       Impact factor: 3.641

Review 10.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.